Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,259 INR | +0.35% |
|
-0.49% | +16.14% |
Jun. 05 | Hindalco-owned Novelis delays US IPO; shares slide | RE |
May. 27 | Aurobindo Pharma Clocks Gains in Fiscal Q4 Consolidated Net Profit | MT |
Sales 2024 | 290B 3.47B | Sales 2025 * | 317B 3.79B | Capitalization | 738B 8.83B |
---|---|---|---|---|---|
Net income 2024 | 31.73B 380M | Net income 2025 * | 39.08B 468M | EV / Sales 2024 | 2.2 x |
Net cash position 2024 * | 18.34B 220M | Net cash position 2025 * | 24.56B 294M | EV / Sales 2025 * | 2.25 x |
P/E ratio 2024 |
20.1
x | P/E ratio 2025 * |
18.9
x | Employees | 23,451 |
Yield 2024 * |
0.34% | Yield 2025 * |
0.39% | Free-Float | 47.97% |
Latest transcript on Aurobindo Pharma
1 day | +0.35% | ||
1 week | -0.49% | ||
Current month | +6.18% | ||
1 month | +7.74% | ||
3 months | +24.49% | ||
6 months | +20.44% | ||
Current year | +16.14% |
![Extreme 1226.25](/images/extremecours_fleche.png)
![Extreme 1109.45](/images/extremecours_fleche.png)
![Extreme 958.5](/images/extremecours_fleche.png)
![Extreme 665.75](/images/extremecours_fleche.png)
![Extreme 397.2](/images/extremecours_fleche.png)
![Extreme 288.85](/images/extremecours_fleche.png)
![Extreme 288.85](/images/extremecours_fleche.png)
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Director of Finance/CFO | - | 12-12-31 | |
B. Adi Reddy
CMP | Compliance Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Founder | 66 | 86-12-25 | |
Director/Board Member | 64 | 03-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 6 M€ | +6.07% | - | |
0.22% | 21 M€ | +7.41% | ||
0.12% | 11 M€ | +4.87% |
Date | Price | Change | Volume |
---|---|---|---|
24-06-14 | 1,259 | +0.35% | 1,525,146 |
24-06-13 | 1,255 | +0.46% | 556,663 |
24-06-12 | 1,249 | -0.64% | 728,599 |
24-06-11 | 1,257 | +0.62% | 659,538 |
24-06-10 | 1,249 | -1.26% | 2,468,196 |
Delayed Quote NSE India S.E., June 14, 2024 at 07:43 am EDT
More quotes![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.14% | 8.83B | |
+50.70% | 791B | |
+41.96% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+18.02% | 246B | |
+1.27% | 225B | |
+11.95% | 218B | |
+3.68% | 160B |
- Stock Market
- Equities
- AUROPHARMA Stock